small molecule

SPRIX

KETOROLAC TROMETHAMINE

Loss of exclusivityloss of exclusivity
CompanyZYLA LIFE SCIENCES US INC

Drug detail

Brand nameSPRIX
Active ingredientKETOROLAC TROMETHAMINE
Strength15.75MG/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalMay 2010
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

SPRIX patent cliff — loss of exclusivity — | CliffBio